Eptinezumab
RxNorm 2282660
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2282660 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: eptinezumab.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Eptinezumab
(Atom ID: 11832919)
PTPrescribable
Designated preferred name (PT):
Eptinezumab
(Atom ID: 12421015)
FNPrescribable
Full form of descriptor (FN):
Eptinezumab (substance)
(Atom ID: 12421016)
PTPrescribable
Designated preferred name (PT):
Eptinezumab-containing product
(Atom ID: 12421019)
FNPrescribable
Full form of descriptor (FN):
Product containing eptinezumab (medicinal product)
(Atom ID: 12421651)
Patient Education
Eptinezumab-jjmr Injection
Eptinezumab-jjmr injection is used to help prevent migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light). Eptinezumab-jjmr injection is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain natural substance in the body that causes migraine headaches.
[Learn More]
* Please review the disclaimer below.